Matches in Wikidata for { <http://www.wikidata.org/entity/Q86169736> ?p ?o ?g. }
Showing items 1 to 81 of
81
with 100 items per page.
- Q86169736 description "clinical trial" @default.
- Q86169736 description "ensayu clínicu" @default.
- Q86169736 description "klinisch onderzoek" @default.
- Q86169736 description "клінічне випробування" @default.
- Q86169736 name "A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Certolizumab Pegol in Combination With Methotrexate in the Treatment of Disease Modifying Antirheumatic Drugs (DMARD)-naïve Adul (2012-01-31)" @default.
- Q86169736 name "A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Certolizumab Pegol in Combination With Methotrexate in the Treatment of Disease Modifying Antirheumatic Drugs (DMARD)-naïve Adul (2012-01-31)" @default.
- Q86169736 type Item @default.
- Q86169736 label "A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Certolizumab Pegol in Combination With Methotrexate in the Treatment of Disease Modifying Antirheumatic Drugs (DMARD)-naïve Adul (2012-01-31)" @default.
- Q86169736 label "A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Certolizumab Pegol in Combination With Methotrexate in the Treatment of Disease Modifying Antirheumatic Drugs (DMARD)-naïve Adul (2012-01-31)" @default.
- Q86169736 prefLabel "A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Certolizumab Pegol in Combination With Methotrexate in the Treatment of Disease Modifying Antirheumatic Drugs (DMARD)-naïve Adul (2012-01-31)" @default.
- Q86169736 prefLabel "A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Certolizumab Pegol in Combination With Methotrexate in the Treatment of Disease Modifying Antirheumatic Drugs (DMARD)-naïve Adul (2012-01-31)" @default.
- Q86169736 P1050 Q86169736-F079A234-4331-461E-83B0-95395A4B0074 @default.
- Q86169736 P1132 Q86169736-4C62EEF3-0DF1-4635-A811-8EF4178BC6FB @default.
- Q86169736 P1476 Q86169736-50690053-2451-4239-945D-3719F916A38F @default.
- Q86169736 P17 Q86169736-07A00059-7ED1-4C50-9554-4DE2DDC388AD @default.
- Q86169736 P17 Q86169736-08F5C8B8-F696-43E1-99DD-F2EC0DF44F3A @default.
- Q86169736 P17 Q86169736-0AEC81D7-4FEF-4091-B42A-A2E03560129E @default.
- Q86169736 P17 Q86169736-1813E313-287C-4139-833B-1C29DD3DADC2 @default.
- Q86169736 P17 Q86169736-18E2D1F6-C124-4367-A448-A4BBFCBF231C @default.
- Q86169736 P17 Q86169736-33141115-A02B-45D4-959D-44B90BFFB5D2 @default.
- Q86169736 P17 Q86169736-429F27B3-BC84-4E31-9623-B0C50033175A @default.
- Q86169736 P17 Q86169736-483CA0E7-2C0A-4728-B577-9123FC8984C1 @default.
- Q86169736 P17 Q86169736-5D568978-0DEA-49F7-BF24-FD20D72AA744 @default.
- Q86169736 P17 Q86169736-6008A1D3-B957-4852-92FE-0BEE364DE23E @default.
- Q86169736 P17 Q86169736-634BA109-AE8A-47B9-BC36-81690EF4632C @default.
- Q86169736 P17 Q86169736-643A7108-31C0-4462-B447-1E95DABD48F3 @default.
- Q86169736 P17 Q86169736-75CD3A61-1C03-483A-8217-A70A559BF1CC @default.
- Q86169736 P17 Q86169736-804073F6-0EE6-4B9D-9AC7-BC27B0B9FD25 @default.
- Q86169736 P17 Q86169736-8DECA068-851A-4904-AAF0-0F068486514C @default.
- Q86169736 P17 Q86169736-B3D73AB7-A1FC-43E5-B8B3-061696D6DDB7 @default.
- Q86169736 P17 Q86169736-C24B5ADA-8EA7-4889-9416-A5888038F1BA @default.
- Q86169736 P17 Q86169736-C7238E2F-516B-48AC-9413-E7D2DC7BF469 @default.
- Q86169736 P17 Q86169736-ECBA33C0-D0B0-4660-B23D-680BA9C4CCC2 @default.
- Q86169736 P17 Q86169736-F1B3129C-E7FA-4DE2-923A-F2CA8FFA9529 @default.
- Q86169736 P17 Q86169736-F9F2D623-0DA3-4C5E-9607-8768801B2F59 @default.
- Q86169736 P1813 Q86169736-ABD3C42C-8413-4BBE-8AEB-0C3751FF4F0D @default.
- Q86169736 P2899 Q86169736-09CB587B-08AF-4122-9803-C0F5F3CC8E1E @default.
- Q86169736 P3098 Q86169736-6D412762-D2B0-4C11-9D9F-87CA63DF3606 @default.
- Q86169736 P31 Q86169736-A56CB051-2A8D-43C9-BE65-7667B730B7D6 @default.
- Q86169736 P4844 Q86169736-DBE56D99-5275-476F-A082-788F3C6BDB20 @default.
- Q86169736 P4844 Q86169736-FFD0A9F7-E8D3-4796-9E1A-EC22F9272607 @default.
- Q86169736 P580 Q86169736-7FC4734A-1663-4F87-8FA8-B0ABA3D7FB53 @default.
- Q86169736 P582 Q86169736-D6871CA1-41C4-4912-9092-0BE7D6328CA2 @default.
- Q86169736 P6099 Q86169736-9C84172F-FFA4-4A4C-9793-428C5D04B06E @default.
- Q86169736 P8363 Q86169736-7771B691-8369-4811-9350-C79F2447085A @default.
- Q86169736 P921 Q86169736-47CE1F66-A567-45B3-95F8-C378302436CE @default.
- Q86169736 P1050 Q170990 @default.
- Q86169736 P1132 "+880" @default.
- Q86169736 P1476 "A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Certolizumab Pegol in Combination With Methotrexate for Inducing and Sustaining Clinical Response in the Treatment of DMARD-Naïve Adults With Early Active Rheumatoid Arthritis" @default.
- Q86169736 P17 Q142 @default.
- Q86169736 P17 Q145 @default.
- Q86169736 P17 Q16 @default.
- Q86169736 P17 Q183 @default.
- Q86169736 P17 Q218 @default.
- Q86169736 P17 Q235 @default.
- Q86169736 P17 Q27 @default.
- Q86169736 P17 Q28 @default.
- Q86169736 P17 Q29 @default.
- Q86169736 P17 Q30 @default.
- Q86169736 P17 Q31 @default.
- Q86169736 P17 Q34 @default.
- Q86169736 P17 Q36 @default.
- Q86169736 P17 Q38 @default.
- Q86169736 P17 Q39 @default.
- Q86169736 P17 Q40 @default.
- Q86169736 P17 Q408 @default.
- Q86169736 P17 Q414 @default.
- Q86169736 P17 Q55 @default.
- Q86169736 P17 Q739 @default.
- Q86169736 P17 Q96 @default.
- Q86169736 P1813 "C-early" @default.
- Q86169736 P2899 "+18" @default.
- Q86169736 P3098 "NCT01519791" @default.
- Q86169736 P31 Q30612 @default.
- Q86169736 P4844 Q412909 @default.
- Q86169736 P4844 Q422232 @default.
- Q86169736 P580 "2012-01-01T00:00:00Z" @default.
- Q86169736 P582 "2014-07-01T00:00:00Z" @default.
- Q86169736 P6099 Q42824827 @default.
- Q86169736 P8363 Q78089383 @default.
- Q86169736 P921 Q422232 @default.